Literature DB >> 15660117

Glucocorticoid remediable aldosteronism (GRA) screening in hypertensive patients from a primary care setting.

F Pizzolo, E Trabetti, P Guarini, P Mulatero, A Ciacciarelli, G S Blengio, R Corrocher, O Olivieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15660117     DOI： 10.1038/sj.jhh.1001821

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  3 in total

1.  A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.

Authors:  G A Kline; J L Pasieka; A Harvey; B So; V C Dias
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

2.  Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.

Authors:  Ihn Suk Lee; Seul Young Kim; Hye Won Jang; Min Kyeong Kim; Ju Hee Lee; Yun Hyeong Lee; Young Suk Jo
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

3.  Glucocorticoid-remediable aldosteronism in a young adult with a family history of Conn's syndrome.

Authors:  Heiko Methe; Sinan Pehlivanli
Journal:  Clin Case Rep       Date:  2018-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.